Faculty Opinions recommendation of Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.

2008 ◽  
Author(s):  
Steven Witkin
Keyword(s):  
Innate Immunity ◽  
Complement Activation ◽  
Crucial Role ◽  
Mannose Binding Lectin ◽  
Polymorphonuclear Cells ◽  
Mannose Binding ◽  
Binding Lectin

scholarly journals ON VASCULAR STENOSIS, RESTENOSIS AND MANNOSE BINDING LECTIN

2016 ◽  
Vol 29 (1) ◽  
pp. 57-59 ◽  
Author(s):  
Barbara Stadler KAHLOW ◽  
Rodrigo Araldi NERY ◽  
Thelma L SKARE ◽  
Carmen Australia Paredes Marcondes RIBAS ◽  
Gabriela Piovezani Ramos ◽  
...  
Keyword(s):  
Innate Immunity ◽  
Ischemia Reperfusion Injury ◽  
Ischemia Reperfusion ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Vascular Stenosis ◽  
Micro Organisms ◽  
The Complement System ◽  
Binding Lectin

Mannose binding lectin is a lectin instrumental in the innate immunity. It recognizes carbohydrate patterns found on the surface of a large number of pathogenic micro-organisms, activating the complement system. However, this protein seems to increase the tissue damage after ischemia. In this paper is reviewed some aspects of harmful role of the mannose binding lectin in ischemia/reperfusion injury.

scholarly journals Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients

2020 ◽  
Vol 120 (12) ◽  
pp. 1720-1724 ◽  
Author(s):  
Michael Hultström ◽  
Robert Frithiof ◽  
Oskar Eriksson ◽  
Barbro Persson ◽  
Miklos Lipcsey ◽  
...  
Keyword(s):  
Critically Ill ◽  
Complement Activation ◽  
Tertiary Hospital ◽  
Mannose Binding Lectin ◽  
Lectin Pathway ◽  
Strongly Correlated ◽  
Increased Risk ◽  
Mannose Binding ◽  
Patients At Risk ◽  
Binding Lectin

AbstractThe ongoing COVID-19 pandemic has caused significant morbidity and mortality worldwide, as well as profound effects on society. COVID-19 patients have an increased risk of thromboembolic (TE) complications, which develop despite pharmacological thromboprophylaxis. The mechanism behind COVID-19-associated coagulopathy remains unclear. Mannose-binding lectin (MBL), a pattern recognition molecule that initiates the lectin pathway of complement activation, has been suggested as a potential amplifier of blood coagulation during thromboinflammation. Here we describe data from a cohort of critically ill COVID-19 patients (n = 65) treated at a tertiary hospital center intensive care unit (ICU). A subset of patients had strongly elevated MBL plasma levels, and activity upon ICU admission, and patients who developed symptomatic TE (14%) had significantly higher MBL levels than patients without TE. MBL was strongly correlated to plasma D-dimer levels, a marker of COVID-19 coagulopathy, but showed no relationship to degree of inflammation or other organ dysfunction. In conclusion, we have identified complement activation through the MBL pathway as a novel amplification mechanism that contributes to pathological thrombosis in critically ill COVID-19 patients. Pharmacological targeting of the MBL pathway could be a novel treatment option for thrombosis in COVID-19. Laboratory testing of MBL levels could be of value for identifying COVID-19 patients at risk for TE events.

scholarly journals Complement-Mediated Neutralization of Dengue Virus Requires Mannose-Binding Lectin

mBio ◽  
2011 ◽  
Vol 2 (6) ◽  
Author(s):  
Panisadee Avirutnan ◽  
Richard E. Hauhart ◽  
Mary A. Marovich ◽  
Peter Garred ◽  
John P. Atkinson ◽  
...  
Keyword(s):  
Dengue Virus ◽  
Human Serum ◽  
Complement Activation ◽  
Insect Cell ◽  
Denv Infection ◽  
Mannose Binding Lectin ◽  
Lectin Pathway ◽  
Denv Serotypes ◽  
Mannose Binding ◽  
Binding Lectin

ABSTRACTMannose-binding lectin (MBL) is a key soluble pathogen recognition protein of the innate immune system that binds specific mannose-containing glycans on the surfaces of microbial agents and initiates complement activation via the lectin pathway. Prior studies showed that MBL-dependent activation of the complement cascade neutralized insect cell-derived West Nile virus (WNV) in cell culture and restricted pathogenesis in mice. Here, we investigated the antiviral activity of MBL in infection by dengue virus (DENV), a related flavivirus. Using a panel of naïve sera from mouse strains deficient in different complement components, we showed that inhibition of infection by insect cell- and mammalian cell-derived DENV was primarily dependent on the lectin pathway. Human MBL also bound to DENV and neutralized infection of all four DENV serotypes through complement activation-dependent and -independent pathways. Experiments with human serum from naïve individuals with inherent variation in the levels of MBL in blood showed a direct correlation between the concentration of MBL and neutralization of DENV; samples with high levels of MBL in blood neutralized DENV more efficiently than those with lower levels. Our studies suggest that allelic variation of MBL in humans may impact complement-dependent control of DENV pathogenesis.IMPORTANCEDengue virus (DENV) is a mosquito-transmitted virus that causes a spectrum of clinical disease in humans ranging from subclinical infection to dengue hemorrhagic fever and dengue shock syndrome. Four serotypes of DENV exist, and severe illness is usually associated with secondary infection by a different serotype. Here, we show that mannose-binding lectin (MBL), a pattern recognition molecule that initiates the lectin pathway of complement activation, neutralized infection of all four DENV serotypes through complement activation-dependent and -independent pathways. Moreover, we observed a direct correlation with the concentration of MBL in human serum and neutralization of DENV infection. Our studies suggest that common genetic polymorphisms that result in disparate levels and function of MBL in humans may impact DENV infection, pathogenesis, and disease severity.

scholarly journals Secondary Cell Wall Polymers ofEnterococcus faecalisAre Critical for Resistance to Complement Activation via Mannose-binding Lectin

2012 ◽  
Vol 287 (45) ◽  
pp. 37769-37777 ◽  
Author(s):  
Stefan Geiss-Liebisch ◽  
Suzan H. M. Rooijakkers ◽  
Agnieszka Beczala ◽  
Patricia Sanchez-Carballo ◽  
Karolina Kruszynska ◽  
...  
Keyword(s):  
Cell Wall ◽  
Complement Activation ◽  
Secondary Cell Wall ◽  
Mannose Binding Lectin ◽  
Cell Wall Polymers ◽  
Mannose Binding ◽  
Binding Lectin

Innate immunity in renal transplantation: The role of mannose-binding lectin

2014 ◽  
Vol 28 (1) ◽  
pp. 21-25 ◽  
Author(s):  
Meritxell Ibernon ◽  
Francesc Moreso ◽  
Daniel Serón
Keyword(s):  
Innate Immunity ◽  
Renal Transplantation ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Binding Lectin

scholarly journals Human Mannose-binding Lectin in Immunity

2004 ◽  
Vol 199 (10) ◽  
pp. 1295-1299 ◽  
Author(s):  
Jean-Laurent Casanova ◽  
Laurent Abel
Keyword(s):  
Complement Activation ◽  
Prospective Studies ◽  
Protective Immunity ◽  
Mannose Binding Lectin ◽  
Counter Selection ◽  
Wide Range ◽  
Mannose Binding ◽  
Severe Infections ◽  
Binding Lectin

Human mannose-binding lectin (MBL) recognizes a wide range of microorganisms and triggers the most ancient pathway of complement activation. However, ∼5% of individuals lack functional serum MBL and have not been found to be prone to severe infections in prospective studies. These data suggest that human MBL is largely redundant for protective immunity and may even have been subject to counter selection because of a deleterious impact.

Sign in / Sign up

Export Citation Format

Share Document